Erenumab Dose 3 clinical trials

Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine

This study is looking at a new medicine called erenumab to see if it can help prevent migraine headaches in children and teenagers aged 6 to 17. We want to find out if it's safe and if it can reduce how often young people get migraines.